Discussing the diagnosis of HPV-OSCC: Common questions and answers

Oral Oncology

Volumn 49, Issue 9, 2013, Pages 863-871

  Fakhry, Carole ^a   D'Souza, Gypsyamber ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Behavior; HPV; Oropharyngeal cancer; Patient counseling; Sexually transmitted infection

Indexed keywords

WART VIRUS VACCINE;

ALCOHOL CONSUMPTION; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RISK; HEAD AND NECK CANCER; HUMAN; MOUTH INFECTION; ORAL SEX; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; PATIENT COUNSELING; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SEXUALITY; SMOKING; SQUAMOUS CELL CARCINOMA; VACCINATION; WART VIRUS;

BEHAVIOR; HPV; OROPHARYNGEAL CANCER; PATIENT COUNSELING; SEXUALLY TRANSMITTED INFECTION;

CARCINOMA, SQUAMOUS CELL; HUMANS; MOUTH NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES;

EID: 84883135984     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.06.002     Document Type: Review

References (79)

1. A.K. Chaturvedi, E.A. Engels, R.M. Pfeiffer, B.Y. Hernandez, W. Xiao, and E. Kim Human papillomavirus and rising oropharyngeal cancer incidence in the United States J Clin Oncol Off J Am Soc Clin Oncol 29 2011 4294 4301
2. Human papillomavirus-associated cancers - United States, 2004-2008. MMWR Morbidity and mortality weekly report 2012; vol. 61. p. 258-61.
3. M.W. Lingen, W. Xiao, A. Schmitt, B. Jiang, R. Pickard, and P. Kreinbrink Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas Oral Oncol 49 2013 1 8
4. M.L. Gillison, G. D'Souza, W. Westra, E. Sugar, W. Xiao, and S. Begum Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers J Natl Cancer Inst 100 2008 407 420
5. K.K. Ang, J. Harris, R. Wheeler, R. Weber, D.I. Rosenthal, and P.F. Nguyen-Tan Human papillomavirus and survival of patients with oropharyngeal cancer New Engl J Med 363 2010 24 35
6. C. Fakhry, W.H. Westra, S. Li, A. Cmelak, J.A. Ridge, and H. Pinto Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial J. Natl Cancer Inst 100 2008 261 269
7. D.G. Pfister, K.-K. Ang, D.M. Brizel, M.L. Gillison, W.M. Lydiatt, and J.P. Shah NCCN practice guidelines for head and neck cancers Oncology (Williston Park) 2012
8. K.E. Weaver, S.C. Danhauer, J.A. Tooze, A.W. Blackstock, J. Spangler, and L. Thomas Smoking cessation counseling beliefs and behaviors of outpatient oncology providers Oncologist 17 2012 455 462
9. R.A. Schnoll, B. Zhang, M. Rue, J.E. Krook, W.T. Spears, and A.C. Marcus Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group J Clin Oncol Off J Am Soc Clin Oncol 21 2003 355 365
10. A.N. Thorndike, N.A. Rigotti, R.S. Stafford, and D.E. Singer National patterns in the treatment of smokers by physicians JAMA J Am Med Assoc 279 1998 604 608
11. T.E. Kottke, M.L. Brekke, L.I. Solberg, and J.R. Hughes A randomized trial to increase smoking intervention by physicians. Doctors Helping Smokers, Round I JAMA J Am Med Assoc 261 1989 2101 2106
12. J. Zabora, K. BrintzenhofeSzoc, B. Curbow, C. Hooker, and S. Piantadosi The prevalence of psychological distress by cancer site Psycho-Oncol 10 2001 19 28
13. E.F. Dunne, A. Friedman, S.D. Datta, L.E. Markowitz, and K.A. Workowski Updates on human papillomavirus and genital warts and counseling messages from the 2010 sexually transmitted diseases treatment guidelines Clin Infect Dis Off Public Infect Dis Soc Am 53 Suppl 3 2011 S143 S152
14. R. Anhang, A. Goodman, and S.J. Goldie HPV communication: review of existing research and recommendations for patient education CA: Cancer J Clin 54 2004 248 259
15. T.C. Davis, M.V. Williams, E. Marin, R.M. Parker, and J. Glass Health literacy and cancer communication CA: Cancer J Clin 52 2002 134 149
16. K.J. Petrie, J.T. Muller, F. Schirmbeck, L. Donkin, E. Broadbent, and C.J. Ellis Effect of providing information about normal test results on patients' reassurance: randomised controlled trial BMJ 334 2007 352
17. T.J. Herzog, and J.D. Wright The impact of cervical cancer on quality of life - the components and means for management Gynecol Oncol 107 2007 572 577
18. E.L. Nelson, L.B. Wenzel, K. Osann, A. Dogan-Ates, N. Chantana, and A. Reina-Patton Stress, immunity, and cervical cancer: biobehavioral outcomes of a randomized clinical trial [corrected] Clin Cancer Res Off J Am Assoc Cancer Res 14 2008 2111 2118
19. H.C. Kitchener, I. Fletcher, C. Roberts, P. Wheeler, M. Almonte, and P. Maguire The psychosocial impact of human papillomavirus testing in primary cervical screening - a study within a randomized trial Int J Gynecol Cancer Off J Int Gynecol Cancer Soc 18 2008 743 748
20. M. Pirotta, L. Ung, A. Stein, E.L. Conway, T.C. Mast, and C.K. Fairley The psychosocial burden of human papillomavirus related disease and screening interventions Sex Trans Infect 85 2009 508 513
21. S. Bell, M. Porter, H. Kitchener, C. Fraser, P. Fisher, and E. Mann Psychological response to cervical screening Prev Med 24 1995 610 616
22. K. McCaffery, J. Waller, S. Forrest, L. Cadman, A. Szarewski, and J. Wardle Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact BJOG: Int J Obstet Gynaecol 111 2004 1437 1443
23. C.C. Doak, L.G. Doak, G.H. Friedell, and C.D. Meade Improving comprehension for cancer patients with low literacy skills: strategies for clinicians CA: Cancer J Clin 48 1998 151 162
24. N. Munoz, X. Castellsague, A.B. de Gonzalez, and L. Gissmann Chapter 1: HPV in the etiology of human cancer Vaccine 24 Suppl 3 2006 (S3/1-10)
25. B.A. Weaver Epidemiology and natural history of genital human papillomavirus infection J Am Osteopath Assoc 106 2006 S2 S8
26. E.F. Dunne, C.M. Nielson, K.M. Stone, L.E. Markowitz, and A.R. Giuliano Prevalence of HPV infection among men: a systematic review of the literature J Infect Dis 194 2006 1044 1057
27. C.B. Woodman, S. Collins, H. Winter, A. Bailey, J. Ellis, and P. Prior Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study Lancet 357 2001 1831 1836
28. V. Dalstein, D. Riethmuller, J.L. Pretet, K. Le Bail Carval, J.L. Sautiere, and J.P. Carbillet Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study Int J Cancer 106 2003 396 403
29. G.Y. Ho, R.D. Burk, S. Klein, A.S. Kadish, C.J. Chang, and P. Palan Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia J Natl Cancer Inst 87 1995 1365 1371
30. K.L. Wallin, F. Wiklund, T. Angstrom, F. Bergman, U. Stendahl, and G. Wadell Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer New Engl J Med 341 1999 1633 1638
31. M.L. Gillison, T. Broutian, R.K. Pickard, Z.Y. Tong, W. Xiao, and L. Kahle Prevalence of oral HPV infection in the United States, 2009-2010 JAMA J Am Med Assoc 307 2012 693 703
32. H. Trottier, and A.N. Burchell Epidemiology of mucosal human papillomavirus infection and associated diseases Public Health Genomics 12 2009 291 307
33. G. D'Souza, C. Fakhry, E.A. Sugar, E.C. Seaberg, K. Weber, and H.L. Minkoff Six-month natural history of oral versus cervical human papillomavirus infection Int J Cancer 121 2007 143 150
34. M.P. Canadas, F.X. Bosch, M.L. Junquera, M. Ejarque, R. Font, and E. Ordonez Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population J Clin Microbiol 42 2004 1330 1332
35. A.R. Giuliano, E. Lazcano-Ponce, L.L. Villa, R. Flores, J. Salmeron, and J.H. Lee The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States Cancer Epidemiol Biomark Prevent 17 2008 2036 2043 (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)
36. Beachler DC, D'Souza G, Sugar EA, Gillison ML. Differences in oral and anal HPV natural history among HIV-infected individuals. 28th International papillomavirus conference, Puerto Rico; 2012. p. 213.
37. D'Souza G, Griffioen AM, Kluz N, Gillison ML. Oral HPV prevalence, six-month persistence and incidence among high-risk young adults. In: 28th International papillomavirus conference, Puerto Rico; 2012. p. 215.
38. G. D'Souza, Y. Agrawal, J. Halpern, S. Bodison, and M.L. Gillison Oral sexual behaviors associated with prevalent oral human papillomavirus infection J Infect Dis 199 2009 1263 1269
39. A.R. Kreimer, A.J. Alberg, R. Daniel, P.E. Gravitt, R. Viscidi, and E.S. Garrett Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus J Infect Dis 189 2004 686 698
40. E.M. Smith, S. Swarnavel, J.M. Ritchie, D. Wang, T.H. Haugen, and L.P. Turek Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents Pediatr Infect Dis J 26 2007 836 840
41. A.R. Kreimer, A. Villa, A.G. Nyitray, M. Abrahamsen, M. Papenfuss, and D. Smith The epidemiology of oral HPV infection among a multinational sample of healthy men Cancer Epidemiol Biomark Prevent 20 2011 172 182 (A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology)
42. Campbell CMP, Kreimer AR, Lin H-Y, Fulp W, Abrahamsen M, Papenfuss MR, et al. Incidence and clearance of oral oncogenic human papillomavirus (HPV) in men (HIM): a cohort study. In: 28th International papillomavirus conference, Puerto Rico; 2012. p. 214.
43. K. Kero, J. Rautava, K. Syrjanen, S. Grenman, and S. Syrjanen Oral mucosa as a reservoir of human papillomavirus: point prevalence, genotype distribution, and incident infections among males in a 7-year prospective study Eur Urol 62 2012 1063 1070
44. G. D'Souza, A.R. Kreimer, R. Viscidi, M. Pawlita, C. Fakhry, and W.M. Koch Case-control study of human papillomavirus and oropharyngeal cancer New Engl J Med 356 2007 1944 1956
45. E.M. Smith, J.M. Ritchie, K.F. Summersgill, J.P. Klussmann, J.H. Lee, and D. Wang Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers Int J Cancer 108 2004 766 772
46. P.V. Chin-Hong, E. Vittinghoff, R.D. Cranston, S. Buchbinder, D. Cohen, and G. Colfax Age-specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study J Infect Dis 190 2004 2070 2076
47. F.A. Castro, W. Quint, P. Gonzalez, H.A. Katki, R. Herrero, and L.J. van Doorn Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica J Infect Dis 206 2012 1103 1110
48. A.G. Nyitray, D. Smith, L. Villa, E. Lazcano-Ponce, M. Abrahamsen, and M. Papenfuss Prevalence of and risk factors for anal human papillomavirus infection in men who have sex with women: a cross-national study J Infect Dis 201 2010 1498 1508
49. D.C. Beachler, K.M. Weber, J.B. Margolick, H.D. Strickler, R.D. Cranston, and R.D. Burk Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults Cancer Epidemiol Biomark Prevent 21 2012 122 133 (A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology)
50. R.K. Pickard, W. Xiao, T.R. Broutian, X. He, and M.L. Gillison The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years Sex Transm Dis 39 2012 559 566
51. Z.R. Edelstein, S.M. Schwartz, S. Hawes, J.P. Hughes, Q. Feng, and M.E. Stern Rates and determinants of oral human papillomavirus infection in young men Sex Transm Dis 39 2012 860 867
52. Trends in HIV-related risk behaviors among high school students - United States, 1991-2011. MMWR Morbidity and mortality weekly, report. 2012; vol. 61. p. 556-60.
53. J. Mork, A.K. Lie, E. Glattre, G. Hallmans, E. Jellum, and P. Koskela Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck New Engl J Med 344 2001 1125 1131
54. Kreimer AR, Johansson M, Waterboer T, Kaaks R, Chang-Claude J, Drogen D, et al. Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol. 2013. [Epub ahead of print].
55. D.C. Beachler, and G. D'Souza Nuances in the changing epidemiology of head and neck cancer Oncology (Williston Park) 24 924 2010 6
56. P.L. Reiter, W.F. Pendergraft 3rd, and N.T. Brewer Meta-analysis of human papillomavirus infection concordance Cancer Epidemiol Biomark Prevent 19 2010 2916 2931 (A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology)
57. D. Saslow, D. Solomon, H.W. Lawson, M. Killackey, S.L. Kulasingam, and J. Cain American cancer society, American society for colposcopy and cervical pathology, and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer CA: Cancer J Clin 62 2012 147 172
58. Y. Agrawal, W.M. Koch, W. Xiao, W.H. Westra, A.L. Trivett, and D.E. Symer Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma Clin Cancer Res Off J Am Assoc Cancer Res 14 2008 7143 7150
59. F. Coutlee, A.M. Trottier, G. Ghattas, R. Leduc, E. Toma, and G. Sanche Risk factors for oral human papillomavirus in adults infected and not infected with human immunodeficiency virus Sex Transm Dis 24 1997 23 31
60. R.L. Winer, J.P. Hughes, Q. Feng, S. O'Reilly, N.B. Kiviat, and K.K. Holmes Condom use and the risk of genital human papillomavirus infection in young women New Engl J Med 354 2006 2645 2654
61. L.W. Huang, and K.M. Seow Oral sex is a risk factor for human papillomavirus-associated nasopharyngeal carcinoma in husbands of women with cervical cancer Gynecol Obstet Invest 70 2010 73 75
62. K. Hemminki, and C. Dong Cancer in husbands of cervical cancer patients Epidemiology 11 2000 347 349
63. K. Hemminki, C. Dong, and M. Frisch Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands Eur J Cancer Prev 9 2000 433 437
64. R. Haddad, C. Crum, Z. Chen, J. Krane, M. Posner, and Y. Li HPV16 transmission between a couple with HPV-related head and neck cancer Oral Oncol 44 2008 812 815
65. R.B. Capone, S.I. Pai, W.M. Koch, M.L. Gillison, H.N. Danish, and W.H. Westra Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma Clin Cancer Res Off J Am Assoc Cancer Res 6 2000 4171 4175
66. A. Graziottin, and A. Serafini HPV infection in women: psychosexual impact of genital warts and intraepithelial lesions J Sex Med 6 2009 633 645
67. C. Fakhry, B.T. Rosenthal, D.P. Clark, and M.L. Gillison Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations Cancer Prev Res (Phila) 4 2011 1378 1384
68. Lambert PF, Yang RZ, Blitzer GC, Smith MA, Armstrong EA, Harari PM, et al. Assessmen of tumor growth rates in response to radiation and chemotherapy treatment in HPV-positive and negative head and neck cancers. In: 28h International papillomavirus conference, Puerto Rico; 2012. p. 92.
69. T.R. Read, J.S. Hocking, L.A. Vodstrcil, S.N. Tabrizi, M.J. McCullough, and A.E. Grulich Oral human papillomavirus in men having sex with men: risk-factors and sampling PLoS ONE 7 2012 e49324
70. M.L. Gillison, Q. Zhang, R. Jordan, W. Xiao, W.H. Westra, and A. Trotti Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer J Clin Oncol Off J Am Soc Clin Oncol 30 2012 2102 2111
71. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morbidity and mortality weekly, report. 2010; vol. 59. p. 630-2.
72. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morbidity and mortality weekly, report. 2010; vol. 59. p. 626-9.
73. D.M. Harper, E.L. Franco, C.M. Wheeler, A.B. Moscicki, B. Romanowski, and C.M. Roteli-Martins Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial Lancet 367 2006 1247 1255
74. S.M. Garland, M. Hernandez-Avila, C.M. Wheeler, G. Perez, D.M. Harper, and S. Leodolter Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases New Engl J Med 356 2007 1928 1943
75. M.L. Gillison Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination J Adol Health Off Public Soc Adol Med 43 2008 S52 S60
76. G. D'Souza, and A. Dempsey The role of HPV in head and neck cancer and review of the HPV vaccine Prev Med 53 Suppl 1 2011 S5 S11
77. R.C. Rose, C. Lane, S. Wilson, J.A. Suzich, E. Rybicki, and A.L. Williamson Oral vaccination of mice with human papillomavirus virus-like particles induces systemic virus-neutralizing antibodies Vaccine 17 1999 2129 2135
78. J.A. Suzich, S.J. Ghim, F.J. Palmer-Hill, W.I. White, J.K. Tamura, and J.A. Bell Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas Proc Nat Acad Sci USA 92 1995 11553 11557
79. D'Souza G, Gross N, Pai SI, Hadded R, Gillisom ML, Posner M. Oral HPV infection in HPV-positive oropharyngeal cancer cases and their spouses. 2013, ASCO meeting, Chicago. Abstract 6031.